VaxGen exploring ways to avoid closing / Merger, partnership eyed after loss of biodefense contract

Officials of VaxGen Inc., a South San Francisco biotechnology company, said they are exploring a merger or partnership to avoid going out of business after the loss of the companys $877.5 million contract to produce an anthrax vaccine stockpile for the U.S….

Read more detail on Legal News Directory – Contract Law

Legal notice about the VaxGen exploring ways to avoid closing / Merger, partnership eyed after loss of biodefense contract rubric : Hukuki Net Legal News is not responsible for the privacy statements or other content from Web sites outside of the Hukuki.net site. Please refer the progenitor link to check the legal entity of this resource hereinabove.

Do you need High Quality Legal documents or forms related to VaxGen exploring ways to avoid closing / Merger, partnership eyed after loss of biodefense contract?

This entry was posted in Contract Law and tagged , , , , , , , , , , . Bookmark the permalink.

Leave a Reply